Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Eyelash Hypotrichosis Clinical Trial

Official title:
A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-daily Application of Bimatoprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy-induced Hypotrichosis of the Eyelashes in Japanese Subjects

Status Completed

Clinical Trial Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes following chemotherapy treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01391286
Study type	Interventional
Source	Allergan
Contact
Status	Completed
Phase	Phase 3
Start date	July 1, 2011
Completion date	May 25, 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01229423` - Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects	Phase 4
Completed	`NCT01623479` - An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Completed	`NCT01064882` - Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence	Phase 2
Completed	`NCT01023841` - Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children	Phase 4
Completed	`NCT01391273` - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis	Phase 3
Completed	`NCT02505776` - Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan